Most Downloaded x-ray structure (1xgj) from Protein Data Bank between 07/2007-08/2008
Maria Paola Costi , Donatella Tondi , F. Morandi , R. Bonnet
1 -1
2008
Effet préventif de l’activité physique sur l’interaction tissu adipeux – microbiote intestinal chez des souris CEABAC10 exposées à la souche AIEC LF82
E. Vazeille , Lydie Combaret , N. Barnich , P Sirvent
JFHOD 2018, Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive
2018
Structural and Thermodynamic analysis of novel inhibitors of beta-lactmases.
Maria Paola Costi , Donatella Tondi , F. Morandi , A. Venturelli
10th β-Lactamase Meeting
2008
A prospective multicentre surveillance study to investigate the risk associated with contaminated sinks in the intensive care unit
R. Sanchez , F. Le Gallou , S. Ben Hadj Yahia , Rémi Gimenes
Clinical Microbiology and Infection
1
2021
Accuracy of a rapid intrapartum group B Streptococcus test: A new immunochromatographic assay.
A. Delabaere , S. Curinier , S. Ughetto , L. Gibold
Journal of gynecology obstetrics and human reproduction 46 ( 5) 449 -453
2
2017
Chromosome-Encoded Class D β-Lactamase OXA-23 in Proteus mirabilis
R. Bonnet , H. Marchandin , C. Chanal , D. Sirot
Antimicrobial Agents and Chemotherapy 46 ( 6) 2004 -2006
80
2002
A Novel Class A Extended-Spectrum β-Lactamase (BES-1) in Serratia marcescens Isolated in Brazil
R. Bonnet , J. L. M. Sampaio , C. Chanal , D. Sirot
Antimicrobial Agents and Chemotherapy 44 ( 11) 3061 -3068
85
2000
First isolation of a CTX-M-3-producing Enterobacter cloacae in France.
Florence Doucet-Populaire , R. Bonnet , J. C. Ghnassia , J. Sirot
Antimicrobial Agents and Chemotherapy 44 ( 11) 3239 -3240
23
2000
Prevalence of β-Lactamases among 1,072 Clinical Strains of Proteus mirabilis: a 2-Year Survey in a French Hospital
C. Chanal , R. Bonnet , C. De Champs , D. Sirot
Antimicrobial Agents and Chemotherapy 44 ( 7) 1930 -1935
42
2000
A novel CTX-M β-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil
R. Bonnet , J. L. M. Sampaio , R. Labia , C. De Champs
Antimicrobial Agents and Chemotherapy 44 ( 7) 1936 -1942
179
2000
Diversity of TEM Mutants in Proteus mirabilis
R. Bonnet , C. De Champs , D. Sirot , C. Chanal
Antimicrobial Agents and Chemotherapy 43 ( 11) 2671 -2677
65
1999
Inhibitor-Resistant TEM-33 β-Lactamase in a Shigella sonnei Isolate
D. Sirot , L. Bret , C. Chanal , R. Bonnet
Antimicrobial Agents and Chemotherapy 45 ( 7) 2179 -2180
10
2001
Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240-->Gly.
R. Bonnet , C. Dutour , J. L. M. Sampaio , C. Chanal
Antimicrobial Agents and Chemotherapy 45 ( 8) 2269 -2275
158
2001
CTX-M-1, CTX-M-3, and CTX-M-14 β-Lactamases from Enterobacteriaceae Isolated in France
C. Dutour , R. Bonnet , H. Marchandin , M. Boyer
Antimicrobial Agents and Chemotherapy 46 ( 2) 534 -537
93
2002
TEM Derivative-Producing Enterobacter aerogenes Strains: Dissemination of a Prevalent Clone
P. Dumarche , C. De Champs , D. Sirot , C. Chanal
Antimicrobial Agents and Chemotherapy 46 ( 4) 1128 -1131
40
2002
Fragment-guided design of subnanomolar β-lactamase inhibitors active in vivo
O. Eidam , C. Romagnoli , G. Dalmasso , S. Barelier
Proceedings of the National Academy of Sciences of the United States of America 109 ( 43) 17448 -17453
50
2012
The MAST® D68C test: an interesting tool for detecting extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae
C. Nourrisson , R. N. Tan , C. Hennequin , L. Gibold
European Journal of Clinical Microbiology & Infectious Diseases 34 ( 5) 975 -983
12
2015
Decreased susceptibility to extended-spectrum cephalosporins of a penicillin-susceptible Streptococcus pneumoniae in meningitis.
C. De Champs , J.M. Constantin , R. Bonnet , D. Guelon
Infection 28 ( 1) 58 -59
5
2000
Structural insights into the loss of penicillinase and the gain of ceftazidimase activities by OXA-145 β-lactamase in Pseudomonas aeruginosa
D. Meziane-Cherif , R. Bonnet , A. Haouz , P. Courvalin
Journal of Antimicrobial Chemotherapy 71 ( 2) 395 -402
8
2016
Utilisation de la gélose VCA3 (bioMérieux) pour l'isolement sélectif des Enterococci résistants à la vancomycine à partir de prélèvements fécaux
J. Delmas , F. Robin , J.-P. Romaszko , R. Baraduc
Pathologie Biologie 53 ( 8) 485 -489
1
2005